Use Code: ND30 And Get 30% OFF | Get Free Delivery With No Minimum Order

Frequently bought together
FEXOFIN 180/MG TAB 30/TAB
- Sku : I-032073
Key features
Fexofin Film-coated tablet 180mg 30 Tabl is a film-coated tablet containing fexofenadine hydrochloride 180 mg. It acts as a selective peripheral H1‑receptor antagonist, blocking histamine at H1 receptors and exhibiting limited blood-brain barrier penetration. It is used to relieve symptoms of seasonal allergic rhinitis and to manage chronic idiopathic urticaria. Available OTC as film-coated tablets in a pack of 30.- Brand: FEXOFIN
- Active Ingredient: FEXOFENADINE HYDROCHLORIDE 180mg
- Strength: 180mg
- Dosage Form: Film-coated tablet
- Pack Size: 30 Tablets
- Route: Oral use
- Prescription Status: OTC
- Therapeutic Class: Antiallergic
- Pharmacological Group: Other Antihistamines
- Drug Class: Second‑generation (non‑sedating) H1 antihistamine (peripheral H1‑receptor antagonist).
- Manufacturer: IND-SWIFT LIMITED
- Country of Origin: India
- SFDA Registration No.: 1-5362-19
- Shelf Life: 48 months
- Storage: store below 30°c
- Symptom Target: Allergy, Runny Nose, Itching
- Sedating: No
Frequently bought together
Indications
Approved Uses
Seasonal allergic rhinitis, chronic idiopathic urticaria
Dosage & Administration
Dosing by Condition
Seasonal allergic rhinitis (adults and children ≥12 years): 180mg once daily. Chronic idiopathic urticaria (adults and children ≥12 years): 180mg once daily. Children 6-11 years: 30mg twice daily (using 30mg or 60mg formulations)
Initial Dose
180mg once daily
Maintenance Dose
180mg once daily
Maximum Dose
180mg per day
Children's Dosage
Seasonal Allergic Rhinitis (6-11 years): 30mg twice daily. Chronic Idiopathic Urticaria (6-11 years): 30mg twice daily. (2-11 years): 30mg twice daily. (6 months-2 years): 15mg twice daily. The 180mg strength is not approved for children under 12 years.
Dose Adjustment Notes
Renal impairment: use a lower dose (commonly 60 mg once daily) in reduced renal function; no routine hepatic dose adjustment; avoid coadministration with fruit juices and separate Al/Mg antacids by ≥2 hours.
How to Take
Swallow the 180 mg film‑coated tablet whole with water; may be taken with or without food; avoid taking with fruit juices (apple/orange/grapefruit); if using Al/Mg antacids, separate by at least 2 hours.
Side Effects
Common Side Effects
Headache, nausea, dizziness, fatigue; less commonly drowsiness/somnolence, dyspepsia; may also include back pain and upper respiratory/viral infection symptoms.
Side Effect Frequency
Common (≥1% to <10%): headache, nausea, dizziness, somnolence/drowsiness; Uncommon (<1%): diarrhea, dry mouth, fatigue; Rare: palpitations/tachycardia, hypersensitivity reactions (e.g., angioedema/anaphylaxis)
Safety & Warnings
Contraindications
Hypersensitivity to fexofenadine (fexofenadine hydrochloride) or to any excipients in the product.
Warnings & Precautions
Use caution in renal impairment (consider lower starting dose); avoid/limit fruit juices that reduce absorption; discontinue and seek care if hypersensitivity occurs.
Age Restriction
For the 180 mg tablet: approved/appropriate for adults and adolescents ≥12 years; not recommended for children <12 years (use age-appropriate lower strengths/forms).
Drug Interactions
Drug Interactions
Antacids containing aluminum/magnesium reduce absorption (separate by ~2 hours); erythromycin/ketoconazole can increase fexofenadine exposure; fruit juices (apple/orange/grapefruit) reduce absorption-avoid or separate.
Interaction Severity
MODERATE: Aluminum/magnesium antacids (reduced absorption-separate by ≥2 hours); erythromycin or ketoconazole (increase fexofenadine exposure). MINOR to MODERATE (clinically relevant): fruit juices (reduced absorption-avoid).
Food Interaction
Take with water; avoid apple/orange/grapefruit juice (decreases absorption); may be taken with or without food (a high‑fat meal can reduce Cmax/AUC but usually not clinically significant for routine use).
Special Populations
Children
Seasonal Allergic Rhinitis (6-11 years): 30mg twice daily. Chronic Idiopathic Urticaria (6-11 years): 30mg twice daily. (2-11 years): 30mg twice daily. (6 months-2 years): 15mg twice daily. The 180mg strength is not approved for children under 12 years.
Kidney Impairment
Renal impairment: start with 60 mg once daily in adults/adolescents (including when using the 180 mg product, a lower-strength product is preferred); no adjustment is typically needed in mild impairment, but reduced starting dose is recommended in moderate-severe renal dysfunction.
Liver Impairment
No adjustment needed.
Storage & Patient Advice
Stopping the Medicine
Safe to stop anytime
Overdose
Possible symptoms: dizziness, drowsiness/fatigue, dry mouth; management is symptomatic/supportive (consider decontamination if recent), and hemodialysis is not effective-seek medical attention/poison center guidance.
Patient Counseling
Take 1 tablet (180 mg) once daily with water; avoid fruit juices; may take with or without food; separate aluminum/magnesium antacids by ≥2 hours; usually non‑drowsy but use caution with driving until you know your response; stop several days before allergy skin testing if instructed; store below 30°C.
Monitoring Requirements
No routine monitoring required
Pharmacology
Mechanism of Action
Selective peripheral H1‑receptor antagonist that blocks histamine at H1 receptors; limited blood-brain barrier penetration, so sedation is minimal.
Onset of Action
Onset typically within ~1 hour (often 30-60 minutes), with peak effect around 2-3 hours.
Duration of Effect
24 hours
Half-Life
11-16 hours (mean ~14.4 hours)
Excretion
Eliminated largely unchanged, mainly via feces (~80%) with a smaller renal component (~10-11% in urine).
Product Information
Available Dosage Forms
For this SFDA-registered product: film‑coated tablet (oral) 180 mg only.
Composition per Dose
Each film-coated tablet: 180mg fexofenadine hydrochloride
Generic Availability
Yes
OTC Alternatives
Other OTC second‑generation antihistamines: cetirizine 10 mg, loratadine 10 mg, levocetirizine 5 mg.
Symptom Target
Allergy, Runny Nose, Itching
Sedating
No
Reviewed by Al Mujtama Pharmacy Medical Review Team. Last reviewed 06-07-2026
-1744229570.gif)















